Woodline Partners’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
SW
Woodline Partners's ASTH Position: Q4 2024 in Review
Woodline Partners sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 182,564 shares — an estimated $10.6M sold.
Woodline Partners first reported a position in ASTH in Q1 2024 and held it in 3 quarters. The position peaked at $10.6M in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.
- Woodline Partners reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
- Woodline Partners sold 182,564 Astrana Health shares in Q4 2024, an estimated $10.6M.
- Woodline Partners first reported a position in Astrana Health in Q1 2024 and held it in 3 quarters.
- Woodline Partners's Astrana Health position peaked at $10.6M in Q3 2024.
- 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.
Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.